Herpetic eye disease.

Herpetic keratitis is a common condition which can produce severe complications. The pattern of disease created by the virus depends on an interaction of virus and host mediated mechanisms. The changes in the epithelium are a consequence of the cytopathic effect of the virus and are related directly to virus replication. Changes produced in the stroma are due to inflammatory mechanisms initiated by the presence of virus antigens. The treatment of epithelial disease is aimed at reducing virus replication. The treatment of stromal disease is directed towards suppressing inflammation without increasing virus replication. Various anti-viral agents are available and each has a different mechanism of action and properties which make each anti-viral agent more suitable in particular situations. Many clinical trials have been conducted which indicate the place of anti-viral agents. The management of stromal disease is more complicated and less information is available from clinical trials to indicate the best possible method of treatment.

[1]  A. Lerner.  Acyclovir reaches clinical trial. , 1982, Annals of internal medicine.

[2]  D. Coster,et al.  Prognostic indicators of herpetic keratitis. Analysis of a five-year observation period after corneal ulceration. , 1981, Archives of ophthalmology.

[3]  D. Coster,et al.  Acyclovir and debridement in the treatment of ulcerative herpetic keratitis. , 1981, American journal of ophthalmology.

[4]  H. Kaufman.  Herpes Simplex Virus Strain Specificity: Virulence Correlates , 1981 .

[5]  D. Coster,et al.  Longitudinal Analysis of Ulcerative Herpetic Keratitis , 1981 .

[6]  L. Missotten,et al.  The Herpes Virus , 1981 .

[7]  D. Coster,et al.  A comparison of acyclovir and idoxuridine as treatment for ulcerative herpetic keratitis. , 1980, The British journal of ophthalmology.

[8]  J. H. Elliott,et al.  HLA antigens in recurrent stromal herpes simplex virus keratitis. , 1980, American journal of ophthalmology.

[9]  F. M. Wilson.  Adverse external ocular effects of topical ophthalmic medications. , 1979, Survey of ophthalmology.

[10]  F. Rapp,et al.  Trigeminal ganglion infection by thymidine kinase-negative mutants of herpes simplex virus. , 1979, Science.

[11]  B. Jones,et al.  Acycloguanosine: antiviral activity in the rabbit cornea. , 1979, The British journal of ophthalmology.

[12]  J. Mcgill,et al.  Treatment of amoeboid herpetic ulcers with adenine arabinoside or trifluorothymidine. , 1979, The British journal of ophthalmology.

[13]  D. Coster,et al.  Herpetic canalicular obstruction. , 1979, British Journal of Ophthalmology.

[14]  G. Thompson,et al.  EFFICACY OF ACYCLOGUANOSINE (WELLCOME 248U) AGAINST HERPES-SIMPLEX CORNEAL ULCERS , 1979, The Lancet.

[15]  M. Grayson.  Diseases of the Cornea , 1979 .

[16]  R. O. Schultz,et al.  Trifluridine in resistant human herpetic keratitis. , 1978, Archives of ophthalmology.

[17]  Coster Dj.  Herpetic keratitis and corneal destruction. , 1978 .

[18]  H. Kaufman,et al.  Leukocyte migration inhibitory factor in HSV infections. , 1978, Investigative ophthalmology & visual science.

[19]  H. B. Ostler,et al.  Glucocorticoid therapy in ocular herpes simplex , 1978 .

[20]  C. Foster,et al.  Trifluorothymidine and idoxuridine therapy of ocular herpes. , 1977, American journal of ophthalmology.

[21]  T. Zimmerman,et al.  HLA types and recurrent corneal herpes simplex infection. , 1977, Investigative ophthalmology & visual science.

[22]  J. Br,et al.  Prospects of prevention of recurrent herpetic eye disease. , 1977 .

[23]  J. Br,et al.  Management of herpetic eye disease. , 1977 .

[24]  J. Br,et al.  Corticosteroids in the management of herpetic eye disease. , 1977 .

[25]  J. Br,et al.  Role of debridement in the treatment of herpetic keratitis. , 1977 .

[26]  D. Easty,et al.  Double--blind clinical trial of adenine arabinoside and idoxuridine in herpetic corneal ulcers. , 1977, Transactions of the ophthalmological societies of the United Kingdom.

[27]  W. Müller,et al.  Effect of 9-beta-D-arabinofuranosyladenine on DNA synthesis in vivo. , 1977, Cancer research.

[28]  G. Holmes,et al.  "Non-responsive" coeliac disease. , 1977, British medical journal.

[29]  B. Fox.  Pharmacology and chemistry of some inhibitors of herpes replication. , 1977, The Journal of antimicrobial chemotherapy.

[30]  H. Kaufman,et al.  Herpetic stromal keratitis-evidence for cell-mediated immunopathogenesis. , 1976, American journal of ophthalmology.

[31]  K. Cantell,et al.  TOPICAL THERAPY OF ULCERATIVE HERPETIC KERATITIS WITH HUMAN INTERFERON , 1976, The Lancet.

[32]  J. Mcgill,et al.  Clinical evaluation of adenine arabinoside and trifluorothymidine in the treatment of corneal ulcers caused by herpes simplex virus. , 1976, The Journal of infectious diseases.

[33]  J. Mcgill,et al.  Current and proposed management of ocular herpes simplex. , 1976, Survey of ophthalmology.

[34]  Pettit Th,et al.  Stromal herpes simplex keratitis. , 1976 .

[35]  C. Dawson,et al.  Herpes simplex eye infections: clinical manifestations, pathogenesis and management. , 1976, Survey of ophthalmology.

[36]  H. B. Ostler.  Herpes simplex: the primary infection. , 1976, Survey of ophthalmology.

[37]  L. Hanna,et al.  Observed relationship between herpetic lesions and antigenic type of Herpesvirus hominis. , 1976, Survey of ophthalmology.

[38]  D. Pavan-Langston.  Clinical evaluation of adenine arabinoside and idoxuridine in the treatment of ocular herpes simplex. , 1975, American journal of ophthalmology.

[39]  D. Easty,et al.  Herpes simplex keratitis and keratoconus in the atopic patient. A clinical and immunological study. , 1975, Transactions of the ophthalmological societies of the United Kingdom.

[40]  L. Hanna,et al.  Diagnosis of Herpesvirus hominis infections in a general hospital laboratory , 1975, Journal of clinical microbiology.

[41]  W. Plunkett,et al.  Metabolism of 9-β-d-Arabinofuranosyladenine by Mouse Fibroblasts , 1975 .

[42]  JoseC. Costa,et al.  ROLE OF Fc RECEPTORS IN HERPES SIMPLEX VIRUS INFECTION , 1975, The Lancet.

[43]  J. G. Stevens,et al.  Maintenance of latent herpetic infection: an apparent role for anti-viral IgG. , 1974, Journal of immunology.

[44]  M. Sullivan,et al.  Ultrastructural localization of herpes simplex virus antigens on rabbit corneal cells using sheep antihuman IgG antihorse ferritin hybrid antibodies. , 1974, Investigative ophthalmology.

[45]  P. Laibson,et al.  Dendritic lesions in herpes zoster ophthalmicus. , 1973, Archives of ophthalmology.

[46]  T. H. Pettit,et al.  Corneal immune response to Herpes simplex virus antigens. , 1973, Journal of immunology.

[47]  J. Baringer,et al.  Recovery of herpes-simplex virus from human trigeminal ganglions. , 1973, The New England journal of medicine.

[48]  B. Roizman,et al.  Infection with herpes-simplex viruses 1 and 2 (second of three parts). , 1973 .

[49]  C. Yee,et al.  Herpesvirus hominis: Isolation from Human Trigeminal Ganglion , 1972, Science.

[50]  A. Nesburn,et al.  Latent herpes simplex virus. Isolation from rabbit trigeminal ganglia between episodes of recurrent ocular infection. , 1972, Archives of ophthalmology.

[51]  D. Pavan-Langston,et al.  A double blind clinical study of adenine arabinoside therapy of viral keratoconjunctivitis. , 1972, American journal of ophthalmology.

[52]  H. Kaufman,et al.  Clinical evaluation of trifluorothymidine in the treatment of herpes simplex corneal ulcers. , 1972, American journal of ophthalmology.

[53]  T. Lehner,et al.  Cell-mediated Immunity in Herpesvirus hominis Infections , 1972, British medical journal.

[54]  W. E. Josey,et al.  Perinatal risk associated with maternal genital herpes simplex virus infection. , 1971, American journal of obstetrics and gynecology.

[55]  T. Chang.  Recurrent viral infection (reinfection). , 1971, The New England journal of medicine.

[56]  J. Melnick,et al.  Investigation of plaque formation in chick embryo cells as a biological marker for distinguishing herpes virus type 2 from type 1. , 1971, The Journal of general virology.

[57]  H. Gaya,et al.  Changes in Gut Flora after Cephalexin Treatment , 1970, British medical journal.

[58]  H. Kaufman,et al.  THE RELATIONSHIP BETWEEN VIRUS CHEMOTHERAPY, SECRETORY ANTIBODY FORMATION AND RECURRENT HERPETIC DISEASE , 1970 .

[59]  B. Roizman,et al.  Concerning the egress of herpes simplex virus from infected cells: electron and light microscope observations. , 1969, Virology.

[60]  T. E. Moore,et al.  Structural changes in chronic herpetic keratitis. Studied by light and electron microscopy. , 1968, Archives of ophthalmology.

[61]  J. Br,et al.  The management of ocular herpes. , 1967, Transactions of the ophthalmological societies of the United Kingdom.

[62]  W. Russell,et al.  QUANTITATIVE ELECTRON MICROSCOPY STUDIES ON THE GROWTH OF HERPES VIRUS USING THE TECHNIQUES OF NEGATIVE STAINING AND ULTRAMICROTOMY. , 1964, Virology.

[63]  C. Heidelberger,et al.  Therapeutic Antiviral Action of 5-Trifluoromethyl-2'-deoxyuridine in Herpes Simplex Keratitis , 1964, Science.

[64]  H. Kaufman,et al.  CHEMOTHERAPY OF HERPES KERATITIS. , 1963, Investigative ophthalmology.

[65]  D. Watson,et al.  AN ELECTRON MICROSCOPE STUDY OF THE ATTACHMENT AND PENETRATION OF HERPES VIRUS IN BHK21 CELLS. , 1963, Virology.

[66]  R. Burns.  A DOUBLE-BLIND STUDY OF IDU IN HUMAN HERPES SIMPLEX KERATITIS. , 1963, Archives of ophthalmology.

[67]  C. Heidelberger,et al.  FLUORINATED PYRIMIDINES. XX. INHIBITION OF THE NUCLEOSIDE PHOSPHORYLASE CLEAVAGE OF 5-FLUORO-2'-DEOXYURIDINE BY 5-TRIFLUOROMETHYL-2'-DEOXYURIDINE. , 1963, Biochimica et biophysica acta.

[68]  H. Kaufman,et al.  Use of 5-iodo-2'-deoxyuridine (IDU) in treatment of herpes simplex keratitis. , 1962, Archives of ophthalmology.

[69]  M. Epstein.  OBSERVATIONS ON THE MODE OF RELEASE OF HERPES VIRUS FROM INFECTED HELA CELLS , 1962, The Journal of cell biology.

[70]  M. Epstein.  OBSERVATIONS ON THE FINE STRUCTURE OF MATURE HERPES SIMPLEX VIRUS AND ON THE COMPOSITION OF ITS NUCLEOID , 1962, The Journal of experimental medicine.

[71]  B. Roizman,et al.  Studies of the determinant antigens of viable cells. I. A method, and its application in tissue culture studies, for enumeration of killed cells, based on the failure of virus multiplication following injury by cytotoxic antibody and complement. , 1961, Journal of immunology.

[72]  W. Russell,et al.  The morphology of herpes virus. , 1960, Virology.

[73]  H. M. Rose,et al.  ELECTRON MICROSCOPIC OBSERVATIONS ON THE DEVELOPMENT OF HERPES SIMPLEX VIRUS , 1959, The Journal of experimental medicine.

[74]  E. D. Kilbourne,et al.  Activation of latent herpes simplex by trigeminal sensory-root section. , 1952, The New England journal of medicine.

[75]  J. Adams.  An Address ON THE MORTALITY OF APPENDICITIS * , 1925, British medical journal.